Clinical Trial Update: Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

View source ↗

Summary

This clinical trial update describes the collection of samples for evaluating the Aptima HBV Quant assay. The study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Aptima HBV Quant assay

Snippet

Sponsor: Hologic, Inc. | Conditions: Hepatitis B, Chronic | Status: COMPLETED